Vidofludimus calcium

SKU: orb1738581

Featured

Description

Vidofludimus hemicalcium (4sc-101; SC12267) is an orally administered small molecule with dual activity as a DHODH inhibitor and FXR modulator. It is a research tool for investigating autoimmune and inflammatory conditions, such as IBD, and has shown potential in preclinical models for metabolic liver diseases.

Research Area

Immunology & Inflammation, Metabolism Research

Images & Validation

−

Key Properties

−

CAS Number	1354012-90-0
MW	375.4
Formula	C₂₀H₁₈FNO₄.1/2Ca
SMILES	COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)[O-])F.COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)[O-])F.[Ca+2]
Target	Others,FXR,Dehydrogenase,Interleukin

Storage & Handling

−

Storage	-20°C
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Compound Identifiers

PubChem CID

56944639 ↗

Key Properties

−

No computed properties available.

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols